| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6241316 | Respiratory Medicine | 2016 | 8 Pages |
Abstract
Fifteen percent of patients with chronic, fibrotic HP displayed evidence of a concurrent defined autoimmune disease or autoimmune features suggestive of CTD. The presence of autoimmunity in patients with chronic, fibrotic HP may portend a poorer prognosis. Future studies are needed to validate these findings and determine the impact of immunosuppressive treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Ayodeji Adegunsoye, Justin M. Oldham, Carley Demchuk, Steven Montner, Rekha Vij, Mary E. Strek,